| 000 | 01121 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517152455.0 | ||
| 264 | 0 | _c20170726 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1002/cpt.723 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNanayakkara, S | |
| 245 | 0 | 0 |
_aTargets for Heart Failure With Preserved Ejection Fraction. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cAug 2017 |
||
| 300 |
_a228-237 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aHeart Failure _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMineralocorticoid Receptor Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 650 | 0 | 4 |
_aStroke Volume _xdrug effects |
| 700 | 1 | _aKaye, D M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 102 _gno. 2 _gp. 228-237 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt.723 _zAvailable from publisher's website |
| 999 |
_c27136891 _d27136891 |
||